GC64936
TD52 dihydrochloride
TD52 dihydrochloride, an Erlotinib derivative, is an orally active, potent cancerous inhibitor of protein phosphatase 2A (CIP2A) inhibitor· TD52 dihydrochloride mediates the apoptotic effect in triple-negative breast cancer (TNBC) cells via regulating the CIP2A/PP2A/p-Akt signalling pathway· TD52 dihydrochloride indirectly reduced CIP2A by disturbing Elk1 binding to the CIP2A promoter· TD52 dihydrochloride has less p-EGFR inhibition and has potent anti-cancer activity
ChemicalMW433.33FormulaC24H18Cl2N4
- CAS number
- —
- Molecular weight
- 433.33
- Formula
- C24H18Cl2N4
- Solubility
- DMSO ： 25 mg/mL (57·69 mM; ultrasonic and warming and heat to 60°C)
- Catalogue number
- GC64936
- Brand
- GLPBIO
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il